
Overview
Curaleaf Poland is a licensed pharmaceutical wholesaler specializing in the acquisition, registration, and distribution of medical cannabis products for prescription use. The company provides pharmacies with access to a range of cannabis-based medicines, including dried and extract products containing THC and cannabinoids, all manufactured under GMP conditions. Curaleaf Poland focuses on expanding patient access to high-quality medical cannabis in the growing market since its legalization in 2017.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News

Curaleaf International Launches CPD-Accredited Medical Cannabis Education Platform for UK Healthcare Professionals
London, 23 June 2026: Curaleaf International, one of the global leaders in medical cannabis, today announces the launch of the Curaleaf Education

Curaleaf Secures Triple Win at the 2026 Business of Cannabis Awards
Every year, Cannabis Europa brings together the people building one of the most complex industries in Europe, researchers, regulators, clinicians,

Curaleaf secures triple win at the 2026 Business of Cannabis Awards
Curaleaf is celebrating wins in three major categories at the 2026 Business of Cannabis Awards: European Company of the Year, Cannabis Clinic of the Year,

Curaleaf has announced the completion of the full acquisition of Four 20 Pharma, a fully EU-GMP & GDP licensed German producer and distributor of medical cannabis.
Curaleaf’s initial agreement with Four 20 Pharma in 2022 acquired a 55% stake, with the remaining 45% completed in April 2026. Ultimately, the full
Industry
Bank accounts
Registered as a VAT taxpayer on 2019-12-24. Active
76 1020 5226 0000 6802 0919 5761
06 1020 5226 0000 6202 0930 7119
64 1020 5226 0000 6602 0637 5218
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 18, 2023 | Transformation |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 26, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,131$1,131 | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations of will on behalf of the company are made by the President of the Management Board. In the case of a management board consisting of two or more members, declarations of will on behalf of the company may be made by the President of the Management Board or the Vice-President of the Management Board independently, or joint action by a member of the management board together with a commercial proxy is required.
Supervisory board
Ownership
| Owner |
|---|
Curaleaf International Limited |
Beneficial owners
| Person | Rights | |
|---|---|---|
Boris Alexis Jordan (60) | Other natural person. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Euroleki Gksp. z o.o. + limited partnership | $6,866,421.91 | euroleki.eu | ||
| Bestpharmasp. z o.o. | $5,786,190.68 | bestpharma.pl | ||
| CarnexS.K.A. | $4,618,202.74 | carnex.pl | ||
| Imarti Poland sp. z o.o.sp. k. | $4,030,681.15 | imarti.eu | ||
| Polska Grupa Farmaceutycznasp. z o.o. | $3,192,376.31 | pgflomza.pl | ||
| Steriwundsp. z o.o. | $2,832,891.51 | steriwund.pl | ||
| Farmbudsp. z o.o. | $2,476,637.88 | farmbud.eu | ||
| Vente Amicalesp. z o.o. | $1,850,028.63 | venteamicale.pl | ||
| PUBE Globalsp. z o.o. | $1,777,827.09 | pubeglobal.com | ||
| Passimedsp. z o.o. | $1,677,642.39 | passimed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-08-22 | Name change (Can4med → Curaleaf Poland) | |
| 2023-01-02 | Entered in the register |
FAQ
Last updated: 2026-07-31